Meghan McGrath
Family · Great Falls, MTNPI 1326753807
Payments from drug & device makers
Across 69 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$157
- Merck$146
- Pfizer$126
- AstraZeneca$71
- Celltrion USA Inc.$61
- AbbVie$56
- plus $682 from 26 others
What the payments were for
- Food & beverage$1,20092%
- Education$1008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 4 | $157 |
| Merck | 9 | $146 |
| Pfizer | 9 | $126 |
| AstraZeneca(2 entities) | 4 | $71 |
| Celltrion USA Inc. | 1 | $61 |
| AbbVie | 3 | $56 |
| Daiichi Sankyo Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| AVEO Pharmaceuticals, Inc. | 3 | $46 |
| Sanofi | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Johnson & Johnson | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Blueprint Medicines Corporation | 2 | $31 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| Iovance Biotherapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $17 |
| Bayer | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Gilead | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Novocure Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Acrotech Biopharma Inc. | 1 | $15 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| Array Biopharma Inc | 1 | $12 |
How this compares
$1,300 in reported general payments places this provider in the 85th percentile of 481 family providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Great Falls
- Amanda MurrayGreat Falls$101K
- Sadra ThomasGreat Falls$7K
- Betsy AkinGreat Falls$6K
- Sydne SkaerGreat Falls$5K
- Sarah PackGreat Falls$4K
- Jennalie GuthmillerGreat Falls$4K
- Casey BarkerGreat Falls$3K
- Courtney FordeGreat Falls$3K
- Kelly TimmerGreat Falls$2K
- April ReynoldsGreat Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.